Vassilis Tsatsaris, Alice-Andrée Mariaggi, Odile Launay, Camille Couffignal, Jessica Rousseau, Pierre Yves Ancel, Estelle Marcault, Yves Ville, Anne-Gaël Cordier, Alexandre Vivanti, Julie Carrara, Dominique Luton, Marc Dommergues, Constance Borie, Gilles Kayem, Vivien Alessandrini, Laurence Lecomte, Jean François Meritet, Marianne Leruez-Ville, François Goffinet, Claire Dubois, Olivier Picone, Christelle Vauloup Fellous
BACKGROUND: The prevalence of COVID-19 infection during pregnancy is not known. COVIPREG is a prospective French multicenter study to assess the seroprevalence at the time of delivery and the maternal and neonatal impact of COVID-19 infection during pregnancy. In order to study factors associated with poor outcomes after COVID-19 Infection during pregnancy and adapt the sample size of the study, a preliminary assessment of the prevalence of SARS-CoV-2 IgG was planned after 500 inclusions in a one perinatal center of Paris area...
December 10, 2020: Journal of Gynecology Obstetrics and Human Reproduction